Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 21;33(7):608.
doi: 10.1007/s00520-025-09642-z.

Breast and prostate cancer survivors' understanding of risk and management of cardiovascular and musculoskeletal side effects of treatment: findings from focus groups

Affiliations

Breast and prostate cancer survivors' understanding of risk and management of cardiovascular and musculoskeletal side effects of treatment: findings from focus groups

Jack Dalla Via et al. Support Care Cancer. .

Abstract

Purpose: Survival after a cancer diagnosis is improving, increasing the importance of understanding and managing long-term treatment-related adverse effects. This study aimed to understand breast and prostate cancer survivors' understanding of how cancer treatment may affect cardiovascular and musculoskeletal health.

Methods: Australian breast and prostate cancer survivors treated with therapies with known cardiovascular adverse effects were recruited via a private cancer care provider. Participants completed an online background questionnaire, then participated in a focus group. Focus groups were recorded, transcribed, then analysed using reflexive thematic analysis.

Results: In total, 26 cancer survivors (15 breast, 11 prostate; mean age 67 years) participated in one of seven focus groups. Three major themes were developed: 1) Focus is on the here and now, not the future-participants were infrequently told that their cancer treatment can have negative long-term effects; 2) Wanting individualised delivery of side-effect information-participants received varying types and amounts of information about side effects, but it was not delivered in a way that best suited them; and 3) Left wondering how to best manage side effects-few participants were provided with information about how to manage long term side effects, despite wanting this information.

Conclusion: Important information about long-term side effects of cancer treatment, and how to manage them, was inconsistently provided to breast and prostate cancer survivors. Information about long-term treatment side effects should be delivered in a flexible, individualised way to better enable cancer survivors to understand the risk and engage in preventative health behaviours.

Keywords: Cancer; Cardiovascular; Musculoskeletal; Survivorship; Treatment side effects.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Edith Cowan University Human Research Ethics Committee (2021–02863-DALLAVIA). Consent to participate: Informed consent was obtained from all individual participants included in the study. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Australian Institute of Health Welfare. Cancer data in Australia. Canberra: AIHW; 2021.
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249 - PubMed
    1. Okwuosa TM, Anzevino S, Rao R (2017) Cardiovascular disease in cancer survivors. Postgrad Med J 93(1096):82–90 - PubMed
    1. Sturgeon KM, Mathis KM, Rogers CJ, Schmitz KH, Waning DL (2019) Cancer Chemother-Induced Musculoskelet Degrad JBMR Plus 3(3):e10187 - PMC - PubMed
    1. Sheean PM, Hoskins K, Stolley M (2012) Body composition changes in females treated for breast cancer: a review of the evidence. Breast Cancer Res Treat 135:663–680 - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources